(Q37301334)

19 August 2017

1 reference

title

Low-grade serous ovarian cancer: a unique disease (English)

1 reference

19 August 2017

1 reference

1

Kathleen M Schmeler

1 reference

19 August 2017

2

David M Gershenson

1 reference

19 August 2017

1 November 2008

1 reference

19 August 2017

Current Oncology Reports

1 reference

19 August 2017

10

1 reference

19 August 2017

6

1 reference

19 August 2017

519-523

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-008-0078-8

19 August 2017

0 references

cites work

Clinical behavior of stage II-IV low-grade serous carcinoma of the ovary

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-008-0078-8

Diverse tumorigenic pathways in ovarian serous carcinoma

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-008-0078-8

Toward the development of a universal grading system for ovarian epithelial carcinoma. I. Prognostic significance of histopathologic features--problems involved in the architectural grading system

21 January 2018

1 reference

12 December 2020

Serous psammocarcinoma of the ovary and peritoneum

1 reference

12 December 2020

An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2/neu, and C-KIT in high-grade neoplasms.

1 reference

12 December 2020

Characterization of active mitogen-activated protein kinase in ovarian serous carcinomas

1 reference

12 December 2020

Molecular pathogenesis of ovarian borderline tumors: new insights and old challenges

1 reference

12 December 2020

Primary peritoneal serous psammocarcinoma with recurrent disease and metastasis: a case report and review of the literature

1 reference

12 December 2020

High-grade ovarian serous carcinoma exhibits significantly higher p16 expression than low-grade serous carcinoma and serous borderline tumour.

1 reference

12 December 2020

Subclassification of ovarian surface epithelial tumors based on correlation of histologic and molecular pathologic data

1 reference

12 December 2020

Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum

1 reference

12 December 2020

Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study

1 reference

12 December 2020

Neoadjuvant chemotherapy followed by surgery and adjuvant chemotherapy in patients with primarily unresectable, advanced-stage ovarian cancer.

1 reference

12 December 2020

Observer variation in histologic classification of malignant and borderline ovarian tumors

1 reference

12 December 2020

Toward the development of a universal grading system for ovarian epithelial carcinoma: testing of a proposed system in a series of 461 patients with uniform treatment and follow-up.

1 reference

12 December 2020

Interpathologist and intrapathologist disagreement in ovarian tumor grading and typing

1 reference

12 December 2020

Mutational analysis of K-ras segregates ovarian serous carcinomas into two types: invasive MPSC (low-grade tumor) and conventional serous carcinoma (high-grade tumor).

1 reference

12 December 2020

Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential

1 reference

12 December 2020

Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation.

1 reference

12 December 2020

Testing of two binary grading systems for FIGO stage III serous carcinoma of the ovary and peritoneum

1 reference

12 December 2020

Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential

1 reference

12 December 2020

Comparison of the clinical behavior of newly diagnosed stages II-IV low-grade serous carcinoma of the ovary with that of serous ovarian tumors of low malignant potential that recur as low-grade serous carcinoma

1 reference

12 December 2020

Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma.

1 reference

12 December 2020

Cancer statistics, 2008

1 reference

12 December 2020

Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis

1 reference

12 December 2020

Differences of chemoresistance assay between invasive micropapillary/low-grade serous ovarian carcinoma and high-grade serous ovarian carcinoma

1 reference

12 December 2020

Grading ovarian serous carcinoma using a two-tier system

1 reference

12 December 2020

Serous psammocarcinoma of the ovary: a case report and review of literature.

1 reference

12 December 2020

Serous psammocarcinoma of the ovary: an unusual finding

1 reference

12 December 2020

Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.

1 reference

12 December 2020

Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma

1 reference

12 December 2020

A new histologic grading index in ovarian carcinoma

1 reference

12 December 2020

Histopathologic grading of ovarian carcinoma: a review and proposal

1 reference

12 December 2020

10.1007/S11912-008-0078-8

Identifiers

DOI

1 reference

release_2pdnplsxmbcdhgh3ssqlwrfm6a

19 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/2pdnplsxmbcdhgh3ssqlwrfm6a

24 November 2022

mapped directly with Wikidata item

PubMed ID

18928667

1 reference

PubMed ID

18928667